Search
photo of Richard Ashcroft

Professor Richard Ashcroft

Deputy Dean

The City Law School

Contact details

Address

Professor Richard Ashcroft T350, Myddelton Street Building
City, University of London
Northampton Square
London EC1V 0HB
United Kingdom

About

Overview

Richard Ashcroft joined City Law School in September 2019 as Deputy Dean and Professor of Bioethics. Previously he was Professor of Bioethics at Queen Mary, University of London, where had had been Deputy and Acting Head of the Department of Law. He is an expert on biomedical research ethics and public health ethics, with more than 200 publications in these fields. He has had numerous public roles, including most recently a year as an Alan Turing Fellow at the Alan Turing Institute (2018-19), working on ethics and artificial intelligence in healthcare.

Qualifications

  1. PhD, University of Cambridge, United Kingdom, Sep 1990 – Dec 1995
  2. BA (Hons), University of Cambridge, United Kingdom, Sep 1987 – Jul 1990

Employment

  1. Chair, Senate Research Ethics Committee, University of London, Aug 2020 – present
  2. Deputy Dean, City, University of London, Sep 2019 – present
  3. Professor of Bioethics, City, University of London, Sep 2019 – present
  4. Professor of Bioethics, Queen Mary University of London, Sep 2007 – Sep 2019
  5. Professor of Biomedical Ethics, Queen Mary University of London, May 2006 – Aug 2007
  6. Lecturer/Senior Lecturer/Reader in Medical Ethics, Imperial College London, Mar 2000 – Apr 2006
  7. Lecturer in Ethics in Medicine, University of Bristol, Jan 1997 – Mar 2000
  8. Research Fellow in Philosophy, University of Liverpool, Nov 1995 – Dec 1996

Languages

French (can read), German (can read) and Italian (can read, speak and understand spoken).

Publications

Publications by category

Books (2)

  1. (2006). Principles of Health Care Ethics. John Wiley & Sons, Ltd. ISBN 978-0-470-02713-4.
  2. (2005). Case Analysis in Clinical Ethics. Cambridge University Press. ISBN 978-0-521-83549-7.

Chapters (13)

  1. Ashcroft, R.E. (2015). Bioethics: Philosophical Aspects. International Encyclopedia of the Social & Behavioral Sciences (pp. 631–636). Elsevier.
  2. (2015). CLINICAL RESEARCH CONTRACTING— A LEGAL PERSPECTIVE. In Outsourcing in Clinical Drug Development (pp. 71–84). CRC Press.
  3. Bell, J., Reed, K.D., Ashcroft, R., Witton, J. and Strang, J. (2012). Treating Opioid Dependence with Opioids. Addiction Neuroethics (pp. 57–74). Elsevier.
  4. Ashcroft, R. (2008). The Troubled Relationship Between Bioethics and Human Rights*. Law and Bioethics (pp. 31–51). Oxford University Press.
  5. Ashcroft, R., Campbell, A.V. and Capps, B. (2007). Ethical Aspects of Developments in Neuroscience and Drug Addiction. Drugs and the Future (pp. 439–465). Elsevier.
  6. Ashcroft, R.E. (2005). Current Epistemological Problems in Evidence-based Medicine. Evidence-based Practice in Medicine and Health Care (pp. 77–85). Springer Berlin Heidelberg.
  7. Ashcroft, R. (2005). ‘Power, corruption and lies’: ethics and power. Case Analysis in Clinical Ethics (pp. 77–94). Cambridge University Press.
  8. Parker, M., Ashcroft, R., Verkerk, M. and Widdershoven, G. (2005). Philosophical reflections. Case Analysis in Clinical Ethics (pp. 225–230). Cambridge University Press.
  9. Ashcroft, R.E. (2004). Bioethics. Gynecologic Cancer (pp. 855–863). Elsevier.
  10. Ashcroft, R.E. Genetic Information and “genetic Identity”. Genetic Information (pp. 207–218). Springer US.
  11. Ashcroft, R.E. and Viens, A.M. Clinical trials. The Cambridge Textbook of Bioethics (pp. 201–206). Cambridge University Press.
  12. Ashcroft, R. Smoking, health and ethics. Public Health Ethics (pp. 85–99). Cambridge University Press.
  13. Ashcroft, R.E. Ethics of Clinical Trials: Social, Cultural and Economic Factors. The Advanced Handbook of Methods in Evidence Based Healthcare (pp. 25–37). SAGE Publications Ltd.

Conference papers and proceedings (2)

  1. Thiele, F. and Ashcroft, R.E. (2005). Bioethics in a small world.
  2. Thiele, F. and Ashcroft, R. Introduction.

Journal articles (31)

  1. Ashcroft, R.E. and Langley, T. (2021). Ethics and Harm Reduction Approaches in Tobacco Control. Nicotine & Tobacco Research, 23(1), pp. 1–2. doi:10.1093/ntr/ntaa228.
  2. Ashcroft, R. (2020). What I Haven't Been Reading During the Pandemic. BIOSOCIETIES, 15(3), pp. 471–472.
  3. Fitzgerald, D., Ashcroft, R., Hollin, G., Karkazis, K., King, N.B., Landecker, H. … Wilson, E.A. (2020). Lockdown texts. BioSocieties, 15(3), pp. 470–499. doi:10.1057/s41292-020-00199-0.
  4. Shaw, S., Hughes, G., Stephens, T., Pearse, R., Prowle, J., Ashcroft, R.E. … Everest, L. (2020). Understanding decision making about major surgery: protocol for a qualitative study of shared decision making by high-risk patients and their clinical teams. BMJ Open, 10(5). doi:10.1136/bmjopen-2019-033703.
  5. Finer, S., Martin, H.C., Khan, A., Hunt, K.A., MacLaughlin, B., Ahmed, Z. … van Heel, D.A. (2019). Cohort Profile: East London Genes & Health (ELGH), a community based population genomics and health study of British-Bangladeshi and British-Pakistani people. International Journal of Epidemiology. doi:10.1093/ije/dyz174.
  6. Cao, K.X., Booth, A., Ourselin, S., David, A.L. and Ashcroft, R. (2018). The legal frameworks that govern fetal surgery in the United Kingdom, European Union, and the United States. Prenatal Diagnosis, 38(7), pp. 475–481. doi:10.1002/pd.5267.
  7. Ashcroft, R. (2018). Bioethics in historical perspective. New Genetics and Society, 37(1), pp. 88–89. doi:10.1080/14636778.2016.1223541.
  8. Ashcroft, R.E. (2018). Law and the perils of philosophical grafts. Journal of Medical Ethics, 44(1), pp. 72–72. doi:10.1136/medethics-2017-104319.
  9. Lin, Y., Osman, M. and Ashcroft, R. (2017). Nudge: Concept, Effectiveness, and Ethics. Basic and Applied Social Psychology, 39(6), pp. 293–306. doi:10.1080/01973533.2017.1356304.
  10. Leber, W., McMullen, H., Anderson, J., Marlin, N., Santos, A.C., Bremner, S. … Griffiths, C. (2015). Promotion of rapid testing for HIV in primary care (RHIVA2): a cluster-randomised controlled trial. The Lancet HIV, 2(6). doi:10.1016/s2352-3018(15)00059-4.
  11. Ashcroft, R.E. (2013). Patents. . doi:10.1002/9781444367072.wbiee511.
  12. Ashcroft, R.E. (2013). TRIPS. . doi:10.1002/9781444367072.wbiee535.
  13. Ashcroft, R.E. (2013). Trade Secrets. . doi:10.1002/9781444367072.wbiee705.
  14. Saunders, R. and Ashcroft, R.E. (2012). Consumer genetics and addiction susceptibility testing-just what the consumer ordered. Addiction, 107(12), pp. 2075–2076. doi:10.1111/j.1360-0443.2012.03937.x.
  15. Priebe, S., Bogic, M., Ashcroft, R., Franciskovic, T., Galeazzi, G.M., Kucukalic, A. … Ajdukovic, D. (2010). Experience of human rights violations and subsequent mental disorders – A study following the war in the Balkans. Social Science & Medicine, 71(12), pp. 2170–2177. doi:10.1016/j.socscimed.2010.09.029.
  16. ASHCROFT, R. (2010). FUTURES FOR BIOETHICS? Bioethics, 24(5), pp. ii–ii. doi:10.1111/j.1467-8519.2010.01821.x.
  17. Priebe, S., Burton, A., Ashby, D., Ashcroft, R., Burns, T., David, A. … McCabe, R. (2009). Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT). BMC Psychiatry, 9(1). doi:10.1186/1471-244x-9-61.
  18. Ashcroft, R.E. (2008). Regulating Biomedical Enhancements in the Military. The American Journal of Bioethics, 8(2), pp. 47–49. doi:10.1080/15265160802015024.
  19. SCHÜKLENK, U.D.O. and ASHCROFT, R. (2007). HIV VACCINE TRIALS: RECONSIDERING THE THERAPEUTIC MISCONCEPTION AND THE QUESTION OF WHAT CONSTITUTES TRIAL RELATED INJURIES. Developing World Bioethics, 7(3), pp. ii–iv. doi:10.1111/dewb_210.x.
  20. Ashcroft, R.E. (2006). Getting what you pay for? International Journal of Drug Policy, 17(3), pp. 238–239. doi:10.1016/j.drugpo.2006.02.002.
  21. ASHCROFT, R.E. (2005). ACCESS TO ESSENTIAL MEDICINES: A HOBBESIAN SOCIAL CONTRACT APPROACH. Developing World Bioethics, 5(2), pp. 121–141. doi:10.1111/j.1471-8847.2005.00108.x.
  22. Ashcroft, R., Burwood, S., Kennedy, J.B., Papineau, D. and Schultz, B. (2005). Head hurters. The Philosophers' Magazine, (30), pp. 57–61. doi:10.5840/tpm20053083.
  23. Ashcroft, R.E. (2004). Gene therapy in the clinic: whose risks? Trends in Biotechnology, 22(11), pp. 560–563. doi:10.1016/j.tibtech.2004.09.007.
  24. Edwards, S.J.L., Ashcroft, R. and Kirchin, S. (2004). Research Ethics Committees: Differences and Moral Judgement. Bioethics, 18(5), pp. 408–427. doi:10.1111/j.1467-8519.2004.00407.x.
  25. Ashcroft, R. (2003). Rules of evidence. The Lancet, 361(9354), pp. 355–355. doi:10.1016/s0140-6736(03)12338-0.
  26. Kent, J., Williamson, E., Goodenough, T. and Ashcroft, R. (2002). Social Science Gets the Ethics Treatment: Research governance and ethical review. Sociological Research Online, 7(4), pp. 1–15. doi:10.5153/sro.755.
  27. Ashcroft, R. (2002). What is clinical effectiveness? Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences, 33(2), pp. 219–233. doi:10.1016/s0039-3681(02)00020-1.
  28. Ashcroft, R. (2001). The Family: Organic and Mechanistic Solidarity. American Journal of Bioethics, 1(3), pp. 22–23. doi:10.1162/152651601750417865.
  29. Ashcroft, R. (2001). How does empathy develop? The Lancet, 357(9250), pp. 153–153. doi:10.1016/s0140-6736(05)71197-1.
  30. (2000). Richard Ashcroft. The Lancet, 356(9227), pp. 440–440. doi:10.1016/s0140-6736(05)73595-9.
  31. Schüklenk, U. and Ashcroft, R. (2000). The ethics of reproductive and therapeutic cloning (research). Monash Bioethics Review, 19(2), pp. 33–44. doi:10.1007/bf03351234.